You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
恆指及科指跌幅擴至1.5%及3.3%尋底 百度、信義光能李寧曾挫近8.5%-14% 惟翰森製藥逆升10%
美國9月核心零售銷售升幅超預期,10月密歇根消費信心初值創半年高也勝預期,但期內消費者一年通脹預期意外七個月來首次急劇惡化至5.1%,美匯指數及十年期債息重越113及4厘之上,市場擔心聯儲局將繼續進取加息抗通脹,美股三大指數上周五由早段續彈逾1%,轉吐1.3%-3.1%,對息口敏感科網股及費城半導體指數沽壓較大,拖累納指跑輸,道指倒跌403點收29,634。然而,美股期貨全面反覆回升不足0.5%。亞太股市除菲股續微升外,全部回吐,尤其是台股回吐2.2%報12,843;日經及澳洲200回吐1.4%,前者半日收26,703,回吐387點。 港匯再度觸及弱方兌換保證,金管局於15日凌晨紐約時段承接25.91億港元沽盤,令本周二(18日)本港銀行體系結餘降至1,040.14億港元,再創逾兩年低。港股繼上周五挑戰萬七失敗大幅收窄至升幅至不足200點結束六連跌後,恆指今早低開107點或近0.7%報16,479,早段曾反覆倒升11點高見16,598行人止步,再度輾轉滑落,最低見16,308,再創11年低,現報16,337,跌250點或1.5%,總成交額453億元。此外,反映中概股表現的金龍中國指數上周五急挫3.9%,本港科指低見3,092再創面世新低,現報3,100,回吐3.3%。 73隻藍籌股普遍向下;內需股以體育用品股李寧(02331.HK)表現最差,股價曾急挫近14%低見50.15元創近五個月低,現報52.5元,急挫9.6%;安踏(02020.HK)低見77.5元創近五個月低,現報79.2元,跌2.9%;非藍籌特步(01368.HK)曾挫8%低見7.12元創近年半低,現報7.4元,跌4.4%。潤啤(00291.HK)及非藍籌青啤(00168.HK)跌近3%-3.5%,分別低見48.2元(創四個月低)及68.5元。 周大福(01929.HK)第二財季內地及香港同店銷售按年升3.4%及21.2%,但澳門同店銷售按年降28.6%。摩通指周大福次季同店銷售符預期,重申「增持」評級。然而,該股今早回升2.7%高見14.7元(受制100天線14.9元),掉頭低見13.64元,現報14.02元,倒跌2.1%。 藥明生物(02269.HK)受惠回購股價連升三天後,今早反覆高見52.4元無以為繼,現報49.7元,回吐2.8%;阿里健康(00241.HK)低見3.16元創近五年半低,現報3.19元,挫3.9%。然而,翰森製藥(03692.HK)逆市續升10%報12.86元,股價一舉重越10天及20天線(11.9-12.15元)。 信義光能(00968.HK)扭轉上周五止跌回升勢,曾挫近11%低見7.16元再創近兩年半低,現報7.26元,挫9.3%。 新經濟股以隨ADR下挫京東(09618.HK)及百度(09888.HK)沽壓最大,股價曾挫6.1%及8.4%低見164.1元及95.65元,分別創逾七個月及上市新低,現報165.3元及96.3元,下挫5.4%及7.8%。阿里(09988.HK)、騰訊(00700.HK)及美團(03690.HK)跌逾2.5%-3.5%,分別低見70.9元(創上市新低)、240.8元(創五年半低)及141.6元。 四大藍籌內房除潤地(01109.HK)反覆逆升0.5%報30.95元外,全部跌逾1%-3%,碧桂園(02007.HK)及龍湖(00960.HK)沽壓最大,報1.39元及18.52元。 然而,料首季純利倍增的中海油(00883.HK)高見9.81元,現報9.77元,續升1.1%,股價重越10天及20天線。 四大藍籌內銀全部反覆向好,尤其是招行(03968.HK)及工行(01398.HK)反覆回升逾1%-2%,現報31.3元及3.65元。港交所(00388.HK)承上周五倒跌4.6%勢,今早進一步低見243.6元屢創近兩年半低獲承接,掉頭高見252.8元,現報247.2元,倒升0.2%。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account